Detalles de la búsqueda
1.
Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study.
Ann Oncol
; 31(12): 1764-1772, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979512
2.
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 studyâ.
Ann Oncol
; 31(12): 1755-1763, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979511
3.
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial.
Ann Oncol
; 28(6): 1346-1351, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28383677
4.
Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis.
Ann Oncol
; 27(1): 49-61, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26487582
5.
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes.
Ann Oncol
; 26(4): 657-668, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25214543
6.
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.
Ann Oncol
; 26(1): 167-172, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344361
7.
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy.
Br J Cancer
; 110(1): 26-33, 2014 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24231947
8.
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor ß (TGFß) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial.
Invest New Drugs
; 32(3): 555-60, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24566706
9.
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomes.
Ann Oncol
; 24(11): 2887-92, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23860612
10.
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial.
Clin Genitourin Cancer
; 19(5): 457-465, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006499
11.
Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 14(6): 494-498, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27262369
12.
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party.
Bone Marrow Transplant
; 51(3): 384-90, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26642334
13.
Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database.
Bone Marrow Transplant
; 52(8): 1218-1220, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28581469
Resultados
1 -
13
de 13
1
Próxima >
>>